Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 16% ± 1% | |
natural killer cell | 4 studies | 18% ± 2% | |
endothelial cell | 3 studies | 20% ± 6% | |
GABAergic neuron | 3 studies | 18% ± 4% | |
glutamatergic neuron | 3 studies | 22% ± 6% | |
dendritic cell | 3 studies | 26% ± 12% |
Insufficient scRNA-seq data for expression of DUSP12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 719.32 | 1445 / 1445 | 100% | 28.13 | 183 / 183 |
lung | 100% | 819.20 | 578 / 578 | 100% | 32.81 | 1155 / 1155 |
ovary | 100% | 927.49 | 180 / 180 | 100% | 27.84 | 430 / 430 |
pancreas | 100% | 513.89 | 328 / 328 | 100% | 26.81 | 178 / 178 |
stomach | 100% | 626.26 | 359 / 359 | 100% | 25.13 | 286 / 286 |
breast | 100% | 921.64 | 459 / 459 | 100% | 35.45 | 1116 / 1118 |
intestine | 100% | 848.99 | 966 / 966 | 100% | 27.17 | 526 / 527 |
uterus | 100% | 1036.88 | 170 / 170 | 100% | 37.53 | 458 / 459 |
brain | 100% | 678.93 | 2634 / 2642 | 100% | 39.19 | 705 / 705 |
skin | 100% | 897.17 | 1809 / 1809 | 100% | 40.16 | 470 / 472 |
thymus | 100% | 923.89 | 653 / 653 | 100% | 25.98 | 602 / 605 |
bladder | 100% | 889.90 | 21 / 21 | 99% | 35.76 | 501 / 504 |
prostate | 100% | 821.43 | 245 / 245 | 99% | 21.96 | 499 / 502 |
liver | 100% | 343.79 | 226 / 226 | 98% | 19.45 | 397 / 406 |
kidney | 100% | 712.80 | 89 / 89 | 97% | 17.69 | 878 / 901 |
adrenal gland | 100% | 617.23 | 258 / 258 | 96% | 23.42 | 221 / 230 |
adipose | 100% | 875.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 859.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.02 | 29 / 29 |
spleen | 100% | 945.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.48 | 1 / 1 |
heart | 98% | 405.30 | 846 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 278.07 | 782 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 15.65 | 76 / 80 |
peripheral blood | 85% | 485.62 | 788 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0036211 | Biological process | protein modification process |
GO_0016311 | Biological process | dephosphorylation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019900 | Molecular function | kinase binding |
GO_0016791 | Molecular function | phosphatase activity |
GO_0008138 | Molecular function | protein tyrosine/serine/threonine phosphatase activity |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | DUSP12 |
Protein name | Dual specificity phosphatase 12 Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity tyrosine phosphatase YVH1) |
Synonyms | |
Description | FUNCTION: Dual specificity phosphatase; can dephosphorylate both phosphotyrosine and phosphoserine or phosphothreonine residues. Can dephosphorylate glucokinase (in vitro) (By similarity). Has phosphatase activity with the synthetic substrate 6,8-difluoro-4-methylumbelliferyl phosphate and other in vitro substrates . . |
Accessions | ENST00000367943.5 ENST00000484291.5 V9GY92 Q9UNI6 ENST00000490591.1 ENST00000464004.2 V9GYV5 |